Christopher S. King
Inova Schar Heart and Vascular
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher S. King as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:51 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06564207 · Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized AdultsInova Health Care Services · not yet recruiting · Acute Respiratory Distress Syndrome, ARDS · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 21 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:51 UTC. The ranking covers the 200 most relevant of 7 PubMed records, and a shared surname and initials can bring in a namesake. All 7 on PubMed
- Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Trial.Clin Infect Dis · 202257 citationsRCR 3.7
- 40 citationsRCR 4.8
- A Phase-2 Exploratory Randomized Controlled Trial of INOpulse in Patients with Fibrotic Interstitial Lung Disease Requiring Oxygen.Ann Am Thorac Soc · 202239 citationsRCR 3.5
- 32 citationsRCR 4.5
- Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.J Heart Lung Transplant · 202428 citationsRCR 5.5
- Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.N Engl J Med · 202620 citationsRCR 10.0
- Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis.N Engl J Med · 20267 citationsRCR 3.5